Home › Benefits › Cancer care on international health insurance

Cancer care on international health insurance

Cancer is the benefit most people buy international cover for and the one they least want to test. IPMIBenefits explains what is paid, where the limits hide and how a past diagnosis is treated at underwriting.

Last updated: 20 October 2026 · Reviewed by IPMIBenefits

In short: Cancer treatment is part of the core of nearly every international plan: consultations, tests and imaging, surgery, chemotherapy, radiotherapy, medicines and follow-up once cancer is diagnosed, usually paid under the cancer or inpatient benefit even when delivered as a day-patient. Check whether treatment is paid in full or to a sub-limit, how high the annual maximum is, your area of cover, and the co-insurance on a long course.

Key takeaways

Chemotherapy and radiotherapy are usually paid under the cancer or inpatient benefit, so a hospital-only plan can still cover them.
The outpatient tests that lead to a diagnosis are usually outpatient claims, which a hospital-only plan may not cover.
Screening with no symptoms sits under wellness, not cancer care, and experimental treatments are usually excluded.
Surgery, admissions and courses of chemotherapy or radiotherapy need pre-authorisation; skipping it can reduce or void the claim.
A past cancer may be excluded, loaded or declined under full medical underwriting, and monitoring in remission can keep a moratorium exclusion in place.

On this page

What cancer cover pays for
How insurers structure cancer cover
Limits, pre-authorisation and networks
What to check in the table of benefits
Cancer, underwriting and pre-existing conditions
Common mistakes with cancer cover
FAQ

What cancer cover pays for

Cancer treatment is part of the core of nearly every international private medical insurance (IPMI) plan. The benefit normally covers the planning and delivery of treatment once cancer is diagnosed: consultations with oncologists, diagnostic tests and imaging, surgery, chemotherapy, radiotherapy, prescribed medicines and follow-up. Bupa Global, for example, lists tests, chemotherapy and radiotherapy, imaging, consultations and prescribed medicines under its cancer benefit, with home chemotherapy where possible.

Two points matter about scope. First, cancer treatment often happens as an outpatient or day-patient, in a chemotherapy day unit or a radiotherapy clinic, yet on most plans it is paid under the cancer or inpatient benefit rather than the outpatient one. That is why a hospital-only plan can still cover a full course of cancer treatment. Now Health SimpleCare CORE, which excludes outpatient treatment, still covers cancer, and APRIL International includes cancer treatment on all four of its published levels.

Second, the pathway to a diagnosis is not always cancer cover. The GP visit, the first scan and the biopsy that lead to a diagnosis are usually outpatient claims, paid under the outpatient benefit if the plan has one. On a hospital-only plan you may pay for the investigations yourself and have the treatment covered. The inpatient versus outpatient guide explains where the line falls.

What is usually not included: screening when there are no symptoms, which sits under wellness; experimental treatments not yet approved in the country of treatment; and treatment for a cancer the insurer excluded at underwriting.

How insurers structure cancer cover

Because cancer sits in the core, the structural differences are subtler than for dental or maternity. They show up in four places.

Paid in full or up to a limit. Some plans pay cancer treatment in full within the overall annual maximum. IPH Emerald lists cancer and organ transplant at full refund, subject to policy, on all three of its levels. Others set a cancer sub-limit, or lower limits on the entry tier.
Which related benefits are included. Reconstructive surgery after a mastectomy, wigs and prostheses, genetic testing, palliative and hospice care, and home nursing are sometimes inside the cancer benefit, sometimes separate, and sometimes excluded. IPH Emerald publishes separate lifetime limits for hospice care that rise by level; HCI Nimbl lists hospice and terminal care under a lifetime limit in its core.
Support services. Second medical opinion services, listed by AXA Global Healthcare, Bupa Global and Now Health WorldCare among others, let you have a diagnosis or treatment plan reviewed by another specialist. Direct access to a cancer specialist without a referral, which Bupa Global lists, shortens the route to treatment.
Area of cover. Cancer is where the choice of area bites. Treatment in the USA is excluded unless the plan includes it, and some plans pay a reduced rate outside the chosen area. Emergency cover abroad does not usually extend to a planned course of chemotherapy.

Across the insurers IPMIBenefits compares, the core cancer promise is similar; the differences are in the extras, the sub-limits and the area. Compare those rather than the headline.

Limits, pre-authorisation and networks

Cancer claims are large and long-running, so the plan's mechanics matter more than for any other benefit.

The annual maximum. A full course of treatment can run across two policy years, and the annual maximum resets at renewal. A plan with a high or unlimited annual maximum is safest for a long illness; a low one may be exhausted by surgery and chemotherapy in a bad year. The limits guide explains why lifetime limits on related benefits also matter here.
Pre-authorisation. Surgery, admissions, and usually each course of chemotherapy or radiotherapy need approval in advance. Allianz Care requires pre-authorisation for inpatient and high-cost treatment and states that it pays a reduced share of an otherwise eligible claim if required pre-authorisation is skipped. Expect a treatment plan from the oncologist to be requested.
Guarantee of payment. Once approved, most insurers settle directly with the hospital. IMG Global issues a Guarantee of Payment to the provider for pre-authorised eligible treatment. This matters for cancer because the bills come monthly and paying first would be impossible for most people.
Usual and customary charges. The insurer pays what is reasonable for the country of treatment. Choosing a hospital that bills far above local norms can leave a shortfall even when the treatment is covered.
Cost sharing. An excess is paid once, but co-insurance applies to every bill. On a long course of treatment, a percentage share can add up quickly, which is why an out-of-pocket maximum, such as the one Cigna Global offers, is worth having. The cost-sharing guide explains the mechanics.

See which plans would hold up through a long illness

Nomi quotes 20+ insurers live and shows the annual maximum, area and cost sharing on every plan.

Start your quote

What to check in the table of benefits

Decision	What to check
Is treatment paid in full?	Whether cancer treatment is paid in full within the annual maximum or subject to its own sub-limit.
How high is the annual maximum?	Whether it would cover surgery, a course of chemotherapy and radiotherapy in one policy year, and whether it is per person.
Are the investigations covered?	Whether the outpatient tests that lead to a diagnosis are covered on your tier, or only the treatment that follows.
Which extras are included?	Reconstructive surgery, prostheses, genetic testing, palliative care, hospice and home nursing, and any lifetime limits on them.
Where can I be treated?	Whether your area of cover includes the country you would choose for treatment, and how the USA is treated.
What will I pay?	The excess, the co-insurance percentage and whether an out-of-pocket maximum caps your share.
What do I need to do first?	The pre-authorisation rules, and whether the insurer will settle directly with the hospital.

Key point: for cancer, the annual maximum, the area of cover and the co-insurance are the three numbers that decide whether the plan works. A plan with a generous cancer benefit but a modest annual maximum and a percentage co-insurance can still leave a large bill.

Cancer, underwriting and pre-existing conditions

A past or current cancer is the most consequential disclosure in international health insurance. Under full medical underwriting, you declare the diagnosis and treatment; the insurer may exclude that cancer and related conditions, apply a loading, decline cover for cancer as a whole, or in some cases decline the application. Under a moratorium, a cancer treated or advised on during the look-back period is excluded until the symptom- and treatment-free period has run, and routine monitoring may count as treatment, which keeps the exclusion in place. AXA Global Healthcare states that its plans are designed for conditions beginning after joining and do not cover pre-existing conditions.

Family history is different. A parent's cancer is not your pre-existing condition and does not normally affect your terms, though screening for inherited risk may need approval, and some insurers list genetic testing among the items that require pre-authorisation.

If you already have a plan that covered a cancer, switching on continued personal medical exclusions or transfer terms may carry your existing position across, where fresh underwriting would exclude it. The pre-existing conditions guide explains those options. For anyone in remission, the terms offered matter far more than the price, and this is a case for talking to an experienced broker before you switch.

Common mistakes with cancer cover

Choosing a low annual maximum to save on premium, then exhausting it in the first year of treatment.
Excluding the USA, or choosing a regional area, without deciding where you would actually want to be treated.
Starting treatment before pre-authorisation and receiving a reduced payment.
Overlooking the co-insurance percentage on a long course of treatment.
Assuming screening is covered under the cancer benefit when it sits under wellness.
Switching insurer after a diagnosis on full medical underwriting and losing cover for the condition.

Cancer cover is the reason to read the plan documents slowly. Nomi can show the annual maximum, the area and the cost-sharing terms on every plan it quotes, and an experienced broker can confirm how an existing diagnosis would be treated before you commit. The evacuation benefit is worth reading alongside, since a serious diagnosis abroad may mean travelling for treatment.

Frequently asked questions

Is cancer treatment covered by international health insurance?

Yes, on nearly every plan, as part of the core cover. Diagnosis once symptoms appear, surgery, chemotherapy, radiotherapy, prescribed medicines and follow-up are normally included, either paid in full within the annual maximum or up to a cancer sub-limit. Related extras such as reconstruction and palliative care vary by plan.

Does a hospital-only plan cover chemotherapy?

Usually yes. Chemotherapy and radiotherapy are often delivered as day-patient or outpatient treatment, but most plans pay them under the cancer or inpatient benefit rather than the outpatient one. What a hospital-only plan may not cover is the outpatient tests that lead to the diagnosis, so check that line separately.

Will I need pre-authorisation for cancer treatment?

Almost always. Surgery, admissions and courses of chemotherapy or radiotherapy must be approved in advance, and the insurer will usually ask for a treatment plan. Once approved, most insurers settle directly with the hospital under a guarantee of payment. Skipping approval can reduce or void the claim on many plans.

I have had cancer before. Can I get cover?

Often, but the terms vary. Under full medical underwriting the insurer may exclude that cancer and related conditions, apply a loading, or decline. Under a moratorium it is excluded until you have been symptom- and treatment-free for the required period. Switch terms may preserve cover you already have; a broker can confirm.

Is cancer screening covered under cancer care?

No. Screening when you have no symptoms, such as a routine mammogram or colonoscopy, sits under the wellness or health-check benefit, which is a separate line with its own limit and often a waiting period. Cancer care starts once there are symptoms to investigate or a diagnosis to treat.

How does IPMIBenefits compare cancer cover?

IPMIBenefits explains what the benefit pays for and where the limits hide, then lets you compare real plans with Nomi, which quotes 20+ insurers live. You see the annual maximum, the area of cover and the cost-sharing terms for each plan next to its price, so you can judge which would hold up through a long illness.

Compare cancer cover across the market

Ask Nomi for plans with high limits and low cost sharing, ranked on real price and explained in plain English.

Start your quote

This page is general information, not personal or medical advice. Prices are indicative and confirmed by the insurer at underwriting. For advice on your situation, speak to an experienced broker.